3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Phase 2
2
Phase EARLY_PHASE1
1
Status
Completed
23
Unknown
19
Recruiting
13
Terminated
3
Active not recruiting
3
Not yet recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Breast Neoplasms
192
Neoplasms
147
Prostatic Neoplasms
101
Lung Neoplasms
90
Carcinoma, Non-Small-Cell Lung
62
Colorectal Neoplasms
59
Head and Neck Neoplasms
52
Pancreatic Neoplasms
46
Carcinoma, Hepatocellular
44
Rectal Neoplasms
42
Brain Neoplasms
41
Multiple Myeloma
39
Colonic Neoplasms
37
Esophageal Neoplasms
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
31
Neoplasm Metastasis
30
Leukemia, Myeloid, Acute
30
Ovarian Neoplasms
29
Lymphoma, Non-Hodgkin
29
Leukemia
29
Lymphoma
28
Motor Activity
25
Hodgkin Disease
24
Uterine Cervical Neoplasms
23
Carcinoma, Renal Cell
23
Pain
22
Lymphoma, Follicular
22
Depression
22
Leukemia, Lymphocytic, Chronic, B-Cell
21
Glioma
21
Interventions
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase NA
×
Terminated
×
Neoplastic Cells, Circulating
×
Clear all
NCT02072616
2026-05-04
CTC-Pancreas
University Hospital, Rouen
Phase NA
Terminated
101 enrolled
NCT03960021
2026-03-27
ARFIM
Institut Bergonié
Phase NA
Terminated
20 enrolled
2 charts
NCT01658332
2015-07-30
CIRCUBRONCH
Central Hospital, Nancy, France
Phase NA
Terminated
59 enrolled